Other reports suggested that endothelial growth factor (EGF)-induced PTX3 production through the activation of the PI3K/Akt and NF-κB pathways increased MMP-9 and fibronectin expression in head and neck cancer cell metastasis. This evidence concerns the gene PTX3 and head and neck cancer.